Research Article
Immunohistochemical Study Using Monoclonal VE1 Antibody Can Substitute the Molecular Tests for Apprehension of BRAF V600E Mutation in Patients with Non-small-Cell Lung Carcinoma
Table 2
Clinicopathological characteristics of patients with mutant BRAF V600E tumors ().
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
F, female; M, male; adeno Ca, adenocarcinoma; squamous Ca, squamous carcinoma; diff, differentiated. |